• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.

作者信息

Johnson R C, Kodner C, Russell M, Girard D

机构信息

Department of Microbiology, University of Minnesota, Minneapolis 55455.

出版信息

J Antimicrob Chemother. 1990 Jan;25 Suppl A:33-8. doi: 10.1093/jac/25.suppl_a.33.

DOI:10.1093/jac/25.suppl_a.33
PMID:2154436
Abstract

The in-vitro and in-vivo susceptibility of Borrelia burgdorferito tetracycline, erythromycin and azithromycin was investigated. A macrodilution broth technique was used to determine MBCs. B. burgdorferi was most susceptible to azithromycin (MBC 0.04 mg/l) followed by erythromycin (MBC 0.16 mg/l) and tetracycline (MBC 1.6 mg/l). Syrian hamsters were used to determine ED50S for the three antimicrobials. Azithromycin was most effective in the elimination of spirochaetes from experimentally infected hamsters with an ED50 of 3.71 (+/- 1.9) mg/kg followed by tetracycline (ED50 15.6 (+/- 4.58) mg/kg). Erythromycin possessed low activity, having an ED50 of 122.2 (+/- 51.9) mg/kg. Tissue concentrations of azithromycin exceeding the MBC were present 24 h after the final treatment.

摘要

相似文献

1
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
J Antimicrob Chemother. 1990 Jan;25 Suppl A:33-8. doi: 10.1093/jac/25.suppl_a.33.
2
In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.莱姆病螺旋体伯氏疏螺旋体对四种抗菌药物的体外和体内敏感性
Antimicrob Agents Chemother. 1987 Feb;31(2):164-7. doi: 10.1128/AAC.31.2.164.
3
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents.莱姆病螺旋体伯氏疏螺旋体对头孢呋辛及其他抗菌药物的体外和体内敏感性比较
Antimicrob Agents Chemother. 1990 Nov;34(11):2133-6. doi: 10.1128/AAC.34.11.2133.
4
Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.青霉素、头孢菌素、大环内酯类、链阳菌素、四环素和氨基糖苷类对伯氏疏螺旋体分离株的比色法体外药敏试验。
Int J Antimicrob Agents. 2000 Jun;15(1):11-7. doi: 10.1016/s0924-8579(00)00116-3.
5
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.克拉霉素、阿奇霉素和红霉素对伯氏疏螺旋体的体外比较活性
Antimicrob Agents Chemother. 1993 Aug;37(8):1704-6. doi: 10.1128/AAC.37.8.1704.
6
Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.
Eur J Clin Microbiol Infect Dis. 1989 Jul;8(7):651-3. doi: 10.1007/BF01968150.
7
In vitro and in vivo antibiotic susceptibility of Lyme disease Borrelia isolated from the ixodid tick in Japan.
J Dermatol. 1995 Dec;22(12):935-8. doi: 10.1111/j.1346-8138.1995.tb03949.x.
8
In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agents.欧洲人伯氏疏螺旋体严格意义上的菌株对抗菌药物的体外敏感性。
Int J Antimicrob Agents. 2013 Mar;41(3):288-91. doi: 10.1016/j.ijantimicag.2012.11.016. Epub 2013 Jan 9.
9
Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.阿奇霉素:抗菌活性、药代动力学特性及临床疗效综述
Drugs. 1992 Nov;44(5):750-99. doi: 10.2165/00003495-199244050-00007.
10
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.阿奇霉素、红霉素和四环素对沙眼衣原体和肺炎衣原体活性的体外评估
Antimicrob Agents Chemother. 1992 Feb;36(2):291-4. doi: 10.1128/AAC.36.2.291.

引用本文的文献

1
In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.伯氏疏螺旋体分离株对三种常用于治疗马莱姆病的抗生素的体外敏感性。
BMC Vet Res. 2017 Sep 29;13(1):293. doi: 10.1186/s12917-017-1212-3.
2
Evaluation of the preventive capacities of a topically applied azithromycin formulation against Lyme borreliosis in a murine model.评价一种局部应用阿奇霉素制剂在小鼠模型中预防莱姆病的能力。
J Antimicrob Chemother. 2011 Dec;66(12):2814-22. doi: 10.1093/jac/dkr371. Epub 2011 Sep 15.
3
Antibiotic treatment of animals infected with Borrelia burgdorferi.
对感染伯氏疏螺旋体的动物进行抗生素治疗。
Clin Microbiol Rev. 2009 Jul;22(3):387-95. doi: 10.1128/CMR.00004-09.
4
Erythromycin resistance in Borrelia burgdorferi.伯氏疏螺旋体对红霉素的耐药性。
Antimicrob Agents Chemother. 2002 Nov;46(11):3637-40. doi: 10.1128/AAC.46.11.3637-3640.2002.
5
Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.阿奇霉素和多西环素用于治疗培养阳性的伯氏疏螺旋体游走性红斑。
Infection. 1996 Jan-Feb;24(1):64-8. doi: 10.1007/BF01780661.
6
Clarithromycin in treatment of early Lyme disease: a pilot study.克拉霉素治疗早期莱姆病:一项试点研究。
Antimicrob Agents Chemother. 1996 Feb;40(2):468-9. doi: 10.1128/AAC.40.2.468.
7
In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G.阿奇霉素对小鼠IV型B族链球菌引起的全身感染和脓毒性关节炎的体内疗效:与红霉素和青霉素G的比较研究
Antimicrob Agents Chemother. 1995 Sep;39(9):1938-47. doi: 10.1128/AAC.39.9.1938.
8
Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.阿奇霉素与多西环素治疗游走性红斑的临床及微生物学研究结果
Infection. 1993 Mar-Apr;21(2):83-8. doi: 10.1007/BF01710737.
9
In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.伯氏疏螺旋体对11种抗菌药物的体外敏感性
Antimicrob Agents Chemother. 1993 Jul;37(7):1444-6. doi: 10.1128/AAC.37.7.1444.
10
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.克拉霉素治疗实验性体内莱姆病的疗效。
Antimicrob Agents Chemother. 1993 Jun;37(6):1329-33. doi: 10.1128/AAC.37.6.1329.